Targeting apoptosis - developing drugs to inhibit Bcl-2 and Mcl-1
Combining radiotherapy and the immune system in lymphomas
Mechanism of action of venetoclax (ABT-199) and its side effects
An overview of the current treatment landscape of non-Hodgkin lymphoma
What is in the future for T-cell lymphoma?